GLP-1 Weight-Loss Drugs Are Getting a Major Upgrade After New FDA Approval

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity treatment around the world, and for the 100 million people in the U.S. impacted by the disease, according to NPR. But Eli Lilly’s oral drug orforglipron is still awaiting approval, with a decision expected by spring.

FDA approves weight loss drug in daily pill form

Regulators at the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication approved to treat obesity. Dr. Jon LaPook has more.
AOL

8 FDA-approved weight loss drugs: What are they & what are their side effects?

Most weight loss drugs are FDA-approved for people with obesity or overweight with a weight-related health condition. A healthcare provider can help you find the best weight loss medication for you. The Food and Drug Administration (FDA) has approved some ...
The American Bazaar

FDA approves Novo Nordisk oral weight-loss drug, shifting obesity market

Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally
Health

Zepbound vs Ozempic: Which Works Better for Weight Loss and How They Compare

If you are considering both Ozempic and Zepbound for weight loss, it can be helpful to compare the two side by side before making a decision.
Feedback